Investor Readiness
Helping early-stage biotechs and start-ups to secure funding.
The team at Boyds is experienced in supporting early-stage and start-up companies with the preparation needed to ensure investor readiness, which we offer through our B-Investor Ready service.
For many early-stage and start-up biotech companies, a key consideration is how to raise the funding required to help progress their programs. The competition for investment is fierce, with investors receiving hundreds of pitch decks every week; being able to stand out and ensure your ask is compelling can be a challenge.
Boyds brings a wealth of experience in supporting early-stage companies, and knows what investors are looking for, how to approach the fundraising process, and how to develop and deliver a compelling pitch that will resonate and attract investment.
By working with Boyds and preparing to B-Investor Ready, clients benefit from having access to a highly experienced team focused on supporting them through the fundraising process, and beyond into development.
How Boyds can help companies B-Investor Ready:
- Identifying the right investors(s): Boyds can help to identify, assess and pre-screen investors, ensuring clients are approaching the right investors and funds, and that their messaging is tailored accordingly.
- Pitch deck review: Drawing on our experience and understanding of what investors are looking for, the team at Boyds will advise you on how to develop the pitch deck into a compelling and focused presentation, with tailored messaging and a clear focus on the unmet medical need(s) that your product(s) will address and ensuring that the pitch deck is scientifically and visually as impactful as it can be.
- Advice and support: The team at Boyds will provide clients with honest and constructive feedback and challenge them to think about their pitch from the investor’s perspective.
- Coaching and presentation skills: Clients have the opportunity to rehearse their pitch in front of the Boyds team, who will provide feedback as well as ask the questions likely to be raised by investors.
- Putting the right team in place: We will advise on the presenter and the presentation team, and having Boyds experts to back-up the pitch can provide our clients the edge when seeking investment.
- Advice on data room set up for due diligence: Boyds can provide guidance on how to ensure that your scientific data and the information required for due diligence is organised in a user-friendly manner, helping to avoid pitfalls and meet investor expectations.
Working with Boyds to support with investor readiness can save you time and effort, helping expedite the process to secure the funding needed to progress your development program.
Find out more about how the team at Boyds can help
Biotech Start-up Support
Speaking with experts who have worked with many different companies and have experience of what works and what doesn’t, can significantly accelerate the development of your new medicine. The team at Boyds has extensive experience in supporting emerging biotech companies, and the expertise to assist clients in planning and executing their development programs, as well as ensuring they are ready for investment.
Tune in to our podcast, Conversations in Drug Development
To discuss how Boyds can help you B-Investor Ready, get in touch.
Get in touch
If you would like to talk to a member of our team about a specific project or area of expertise, then please complete this form and we will get in touch.
